• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰西部地区人群对新冠病毒的体液免疫反应。

Humoral response against COVID-19 in the population of western region of Poland.

作者信息

Siedlecka Dominika, Ludziejewska Aleksandra, Bielawska Lena, Baszczuk Aleksandra, Gawron Marta, Danielewicz Mikołaj, Wysocka Ewa

机构信息

Department of Laboratory Diagnostics, Poznan University of Medical Sciences, Poznan, Poland.

Laboratory, Miedzyrzecz Hospital, Miedzyrzecz, Poland.

出版信息

Front Public Health. 2025 Aug 5;13:1648937. doi: 10.3389/fpubh.2025.1648937. eCollection 2025.

DOI:10.3389/fpubh.2025.1648937
PMID:40837952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12361232/
Abstract

BACKGROUND

Exposure to the SARS-CoV-2 activates two forms of active immunity: natural appearance after infection and vaccine induced immunity.

METHODS

We have conducted a retrospective analysis the serum concentration of IgG antibodies against SARS-CoV-2 in the population of Poznan University Clinical Hospital (PH) and Miedzyrzecz Hospital (MH) from 2021 to 2023.

RESULTS

In the entire study population ( = 3,104), as well as in the PH ( = 1,746) and MH ( = 1,358) groups, no significant differences in age ( = 0.1455) or BAU/ml values ( = 0.7874) between women and men were found. Significant differences were observed between the 18-35 and 36-60 age subgroups compared to the >60 age subgroup in the entire study population ( = 0.0022;  = 0.0001) and the PH group ( = 0.0176;  = 0.0003). In the MH group, significant differences were seen between the 18-35 and 36-60 age subgroups ( = 0.0305), as well as between the 18-35 and >60 age subgroups ( = 0.0050). A positive correlation was found between the number of infections and the number of tests conducted in each study group (R = 0.59,  = 0.0016).

CONCLUSION

The concentration of anti-SARS-CoV-2 IgG antibodies is significantly higher in individuals over 60 years old compared to those in the 18-35 and 36-60 age groups. The correlations between age and antibody levels were significant but weak, suggesting that age should not be considered the main factor in predicting the immune response after vaccination or COVID-19 infection. Both women and men presented a similar immune responses to SARS-CoV-2 during the pandemic. Additionally, the number of infections within a specific time period influenced the number of individuals tested for anti-SARS-CoV-2 antibodies.

摘要

背景

接触严重急性呼吸综合征冠状病毒2(SARS-CoV-2)会激活两种主动免疫形式:感染后的自然出现和疫苗诱导的免疫。

方法

我们对波兹南大学临床医院(PH)和米德济热茨医院(MH)2021年至2023年人群中抗SARS-CoV-2 IgG抗体的血清浓度进行了回顾性分析。

结果

在整个研究人群(n = 3104)以及PH组(n = 1746)和MH组(n = 1358)中,未发现女性和男性在年龄(p = 0.1455)或BAU/ml值(p = 0.7874)上有显著差异。在整个研究人群(p = 0.0022;p = 0.0001)和PH组(p = 0.0176;p = 0.0003)中,与60岁以上年龄亚组相比,18 - 35岁和36 - 60岁年龄亚组之间观察到显著差异。在MH组中,18 - 35岁和36 - 60岁年龄亚组之间(p = 0.0305)以及18 - 35岁和60岁以上年龄亚组之间(p = 0.0050)存在显著差异。在每个研究组中,感染次数与检测次数之间发现正相关(R = 0.59,p = 0.0016)。

结论

与18 - 35岁和36 - 60岁年龄组相比,60岁以上个体的抗SARS-CoV-2 IgG抗体浓度显著更高。年龄与抗体水平之间的相关性显著但较弱,这表明年龄不应被视为预测疫苗接种或新冠病毒感染后免疫反应的主要因素。在疫情期间,男性和女性对SARS-CoV-2均呈现出相似的免疫反应。此外,特定时间段内的感染次数影响了检测抗SARS-CoV-2抗体的个体数量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/ebd7813cb786/fpubh-13-1648937-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/d82e78089c29/fpubh-13-1648937-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/64d216fdf0e1/fpubh-13-1648937-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/1dd47744871e/fpubh-13-1648937-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/6e29a0f8f351/fpubh-13-1648937-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/b21eb4e3d416/fpubh-13-1648937-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/747648577853/fpubh-13-1648937-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/6edb9c2b6b3e/fpubh-13-1648937-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/d111130c6fbf/fpubh-13-1648937-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/ebd7813cb786/fpubh-13-1648937-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/d82e78089c29/fpubh-13-1648937-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/64d216fdf0e1/fpubh-13-1648937-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/1dd47744871e/fpubh-13-1648937-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/6e29a0f8f351/fpubh-13-1648937-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/b21eb4e3d416/fpubh-13-1648937-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/747648577853/fpubh-13-1648937-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/6edb9c2b6b3e/fpubh-13-1648937-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/d111130c6fbf/fpubh-13-1648937-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/12361232/ebd7813cb786/fpubh-13-1648937-g009.jpg

相似文献

1
Humoral response against COVID-19 in the population of western region of Poland.波兰西部地区人群对新冠病毒的体液免疫反应。
Front Public Health. 2025 Aug 5;13:1648937. doi: 10.3389/fpubh.2025.1648937. eCollection 2025.
2
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
3
Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study.在整个 COVID-19 大流行期间健康献血者的抗 SARS-CoV-2 总免疫球蛋白和中和抗体反应:一项纵向观察研究。
Swiss Med Wkly. 2024 Jul 1;154:3408. doi: 10.57187/s.3408.
4
Comparison of SARS-CoV-2 IgG responses in hemodialysis patients and healthcare workers after COVID-19 vaccination.新冠病毒疫苗接种后血液透析患者与医护人员中新冠病毒IgG反应的比较。
Front Immunol. 2025 Jul 15;16:1586468. doi: 10.3389/fimmu.2025.1586468. eCollection 2025.
5
Estimation of Anti-SARS-CoV-2 IgM/IgG Seroprevalence Among Non-Vaccinated and Vaccinated University Students: A Cross-Sectional Egyptian Study.未接种和已接种疫苗的大学生中抗SARS-CoV-2 IgM/IgG血清流行率的估计:一项埃及横断面研究。
Viruses. 2025 Mar 6;17(3):378. doi: 10.3390/v17030378.
6
COVID-19 Vaccines2019冠状病毒病疫苗
7
The Second Round of a Population-Based Seroprevalence Study of Anti-SARS-CoV-2 Antibodies and COVID-19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina.波斯尼亚和黑塞哥维那斯普斯卡共和国第二轮基于人群的抗SARS-CoV-2抗体血清流行率研究及新冠疫苗接种评估
Influenza Other Respir Viruses. 2025 Jan;19(1):e70053. doi: 10.1111/irv.70053.
8
The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2.早期使用康复期血浆治疗新冠病毒病对严重急性呼吸综合征冠状病毒2抗体反应的影响。
Microbiol Spectr. 2025 Jul;13(7):e0300624. doi: 10.1128/spectrum.03006-24. Epub 2025 Jun 9.
9
Sero-prevalence of SARS-CoV-2 antibodies in Ethiopia: Results of the National Population Based Survey, 2021.埃塞俄比亚2019冠状病毒病抗体血清流行率:2021年全国人口调查结果
PLoS One. 2025 May 6;20(5):e0313791. doi: 10.1371/journal.pone.0313791. eCollection 2025.
10
Placental transfer of SARS-CoV-2 antibodies in mother-neonate pairs: a prospective nested cohort study.母婴对中 SARS-CoV-2 抗体的胎盘转运:一项前瞻性巢式队列研究。
BMC Infect Dis. 2025 Jul 1;25(1):875. doi: 10.1186/s12879-025-11225-6.

本文引用的文献

1
Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status - United States, April 2021-September 2022.2021 年 4 月至 2022 年 9 月期间,按 COVID-19 疫苗接种状况划分的献血者中 SARS-CoV-2 血清流行率和原发性 SARS-CoV-2 感染发生率估计值-美国。
MMWR Morb Mortal Wkly Rep. 2023 Jun 2;72(22):601-605. doi: 10.15585/mmwr.mm7222a3.
2
B lymphocytes in COVID-19: a tale of harmony and discordance.COVID-19 中的 B 淋巴细胞:一个和谐与失调的故事。
Arch Virol. 2023 Apr 29;168(5):148. doi: 10.1007/s00705-023-05773-y.
3
Infectious diseases in Poland in 2020.
2020年波兰的传染病
Przegl Epidemiol. 2022;76(4):514-527. doi: 10.32394/pe.76.47.
4
Eight Months of Serological Follow-Up of Anti-SARS-CoV-2 Antibodies in France: A Study among an Adult Population.法国对 SARS-CoV-2 抗体的 8 个月血清学随访:一项针对成年人群的研究。
Int J Environ Res Public Health. 2022 Nov 18;19(22):15257. doi: 10.3390/ijerph192215257.
5
Longitudinal monitoring of SARS-CoV-2 spike protein-specific antibody responses in Lower Austria.奥地利下奥地利州对 SARS-CoV-2 刺突蛋白特异性抗体反应的纵向监测。
PLoS One. 2022 Jul 27;17(7):e0271382. doi: 10.1371/journal.pone.0271382. eCollection 2022.
6
Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus.塞浦路斯人群中针对 SARS-CoV-2 的免疫球蛋白 G 抗体的血清阳性率。
PLoS One. 2022 Jun 13;17(6):e0269885. doi: 10.1371/journal.pone.0269885. eCollection 2022.
7
Adaptive Immune Responses and Immunity to SARS-CoV-2.适应性免疫反应与对 SARS-CoV-2 的免疫
Front Immunol. 2022 May 4;13:848582. doi: 10.3389/fimmu.2022.848582. eCollection 2022.
8
Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare personnel.BNT162b2 疫苗第三剂对医护人员定量 SARS-CoV-2 刺突 1-2 IgG 抗体滴度的影响。
PLoS One. 2022 Mar 2;17(3):e0263942. doi: 10.1371/journal.pone.0263942. eCollection 2022.
9
Anti-Spike SARS-CoV-2 IgG Assessment with a Commercial Assay during a 4-Month Course after COVID-19 Vaccination.在新冠疫苗接种后4个月的疗程中,使用商业检测法评估抗新冠病毒刺突蛋白IgG
Vaccines (Basel). 2021 Nov 20;9(11):1367. doi: 10.3390/vaccines9111367.
10
The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273.接种 BNT162b2 和 mRNA-1273 后 T 细胞和 B 细胞应答的时程变化。
Clin Microbiol Infect. 2022 May;28(5):701-709. doi: 10.1016/j.cmi.2021.09.006. Epub 2021 Sep 20.